Quantcast
  • E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

BrainStorm Starts Preclinical Parkinson's Trial

Posted on: Wednesday, 14 February 2007, 15:01 CST

BrainStorm Cell Therapeutics has initiated a safety trial using its adult stem cell technology in an animal model of Parkinson's disease.

BrainStorm's adult stem cell technology has shown efficacy in animal models of Parkinson's disease in previous preclinical trials.

In those studies, stem cells derived from human bone-marrow were differentiated into astrocyte-like cells (supporting cells) and transplanted into mice and rats brains. The engrafted cells survived, kept their function and significantly improved the motor symptoms of Parkinson's disease animal models over a long period of time.

The study is being carried out in collaboration with the Center for Applied Medical Research (CIMA) of the University of Navarra in Pamplona, Spain.

BrainStorm's initial focus is on Parkinson's disease, although its technology has promise for treating several others diseases including multiple sclerosis, ALS, Huntington's disease and stroke.


Source: Datamonitor

More News in this Category


Related Articles



Rating: 1.0 / 5 (3 votes)
Rate this article:
1/52/53/54/55/5

User Comments (1)

1. Posted by Michael Hinz on 02/16/2007, 11:27
This is old news. Adult stem cell transplants into humans have successfully been done done in the U.S. and in China. i.e.: http://www.lifeissues.org/cloningstemcell/adultstemsuccess.htm and http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/10-24-2006/0004458177&EDATE=

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required

redOrbit Friends